Friday, 30 August

16.00-17.00 Pre-symposium I, Otsuka  (chair Kaj Metsärinne, Turku, FIN)
Introduction by Viktoria Sjöblom
Management of ADPKD 2019; learning and practical perspectives from Cologne
Thomas Benzing 
17.00-18.00 Pre-symposium II, Astellas, (chair Kaj Metsärinne, FIN)
Kidney transplantation seen from a  patient perspective – the responsibility for a successful outcome
Sari Högström, Executive Director, The Finnish Kidney and Liver Association & Vilma Niemi, Patient Representative, The Finnish Kidney and Liver Association
18.00-18.20 Coffee break
18.20-19.00 Candle light lecture: Is the progression of DKD preventable?
Prof. Dick de Zeeuw, Groningen, NL
19.30- Get-together party

Saturday, 31 August

8.00-9.00 Industry symposium 1, Nordic Medcom
End Stage Renal Disease Challenges with Volume Overload, Heart Failure and Hypertension”
Survival After End Stage Renal Failure: Preventing Cardiac Death in ESRD Patients – Allan Collins
More Frequent Therapy in Europe: The Key to Volume and Symptom Control? – Mari Vilpakka
A Patient Experience on Fluid Management and Blood Pressure Control – Johan Sandström
9.00-10.30 Session 1 – Transplantation (chair: Kaj Metsärinne, Turku, FIN & Mai Rosenberg, EST)
Optimizing the living donor pool – experiences from a successful exchange program
J. van de Wetering, Rotterdam, NL
Risks for the living donor
Geir Mjoen, Oslo, NO
Current risks and benefits for the kidney transplant recipient
Ilkka Helanterä, Helsinki, FIN
10.30-11.00 Coffee & exhibition
11.00-12.30 Session 2 – Hypertension (chair: Ilkka Pörsti, Tampere, FIN) 
Atherosclerotic renovascular disease
Niina Koivuviita, Turku, FIN
Fibromuscular dysplasia: from an uncommon cause of renovascular hypertension to a less rare systemic arterial disease
Alexandre Persu, Brussels, BEL
12.30-13.30 Lunch and exhibition
13.30-15.00 Session 3 – Diabetes and kidney disease (chair Per-Henrik Groop, FIN & Marius Miglinas, Vilnius, LTU)
New classification of diabetes – implications for DKD?
Leif Groop, FIN & SWE
Functional MRI – the new kidney biopsy?
Aghogho Odudu, Manchester, UK
Diabetic complications in individuals living with type 1 diabetes for more than 50 years
D. Pongrac-Barlovic Ljubljana, SLO
15.00-15.30 Coffee and exhibition
15.30-16.30 Session 4 – Genetics and pathophysiology of renal diseases (chair: Hannu Jalanko, Helsinki, FIN)
Complement system in kidney disease
Seppo Meri, Helsinki, FIN
Podocyte genetics and pathology in CKD
Jaakko Patrakka, Stockholm, SWE
16.30-17.30 Industry symposium 2, Vifor Pharma Nordiska Ab
Hyperkalemia and iron deficiency in the cardiorenal patient – what should treatment aim for?
What are the treatment options that allows for management of the comorbid CKD patient and what challenges are involved?
Satu Mäkelä, Tampere University Hospital, FIN
Knut Aasarød, St Olav University Hospital, NOR
Marie Evans, Karolinska Institutet, SWE
18.00- Jogging by the river Aura with colleagues from Turku
Congress dinner

Sunday, 1 September

8.00-9.00 Industry symposium 3, Baxter Oy
9.00-10.30 Session 5 – Homedialysis (chair Eero Honkanen, Helsinki, FIN)
Critical analysis of Quality of life in different dialysis modalities
Patrik Finne, Helsinki, FIN
Health economic perspectives on home dialysis
Helena Rydell, Stockholm, SWE
Role of home dialysis in dialysis strategy planning
Marianne Rix, Copenhagen, DEN
10.30-11.00 Coffee & exhibition
11.00-12.30 Session 6 – State-of-the-art (chair Mikko Haapio, Helsinki, FIN)
Treatment of IgA nephropathy
Thomas Rauen, Aachen, GER
Claudio Ronco, Vicenza, ITA
12.30-13.40 Lunch and exhibition
13.40-15.00 Session 7 – eHealth (chair Satu Mäkelä, Tampere, FIN)
Digitalization and the change in healthcare
Visa Honkanen, Helsinki, FIN
Digital innovations in nephrology
Virpi Rauta, Helsinki, FIN
15.00-15.30 Coffee and exhibition
15.30-17.00 Session 8 – Best posters (Chair Aivars Pētersons, LVA)
Exploring histological and clinical predictors of 1-year ESRD risk in ANCA-GN presenting with eGFR≤15ml/min/1,73m2
Lars Bostad, Bergen, NOR
Primary renal disease and effect of comorbidities on survival of patients on renal replacement therapy
Patrik Finne, Helsinki, FIN
Fractures and their sequelae in non-dialysis dependent chronic kidney disease; the Stockholm CREAtinine Measurements (SCREAM) project
Björn Runesson, Stockholm, SWE
Prevalence of low bone volume and fractures after kidney transplantation
Satu Keronen, Helsinki, FIN
17.00-18.00 Industry symposium 4, Sanofi
19.30- Congress dinner

Monday, 2 September

9.00-10.00 Industry symposium 4, Medans Oy
10.00-11.30 Session 9 – Geriatric nephrology  (Chair: Heikki Saha, Tampere, FIN)
Shared decision making and the option of conservative treatment
James Heaf, Copenhagen, DEN
Transplantation in the elderly
Kristian Heldal, Oslo, NOR
Palliative treatment of ESRD patients
Edwina Brown, London, UK
11.30-12.00 Coffee and exhibition
12.00-13.30 Session 10 – State of the Art lectures  (chairs: Kaj Metsärinne, Turku, FIN & Helle Thiesson, DEN)
Vasculitis 2019
Mårten Segelmark, Lund, SWE
The gut-kidney axis
Peter Rossing, Copenhagen, DEN
Treatment of Membranous glomerulonephritis 
Eero Honkanen, Helsinki, FIN
13.30- Farewell

Changes to programme are possible.

Preliminary Session Topics


  • eHealth
  • Geriatric nephrology
  • Homedialysis
  • Transplantation
  • Diabetes and kidney disease
  • Hypertension
  • Coagulation defects in kidney disease
  • Pediatric nephrology
  • Best posters
  • State of the art lectures
  • Acute kidney injury